rs758715543
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_053025.4(MYLK):c.1786G>A(p.Ala596Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000179 in 1,566,144 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_053025.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152284Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000172 AC: 3AN: 174056Hom.: 0 AF XY: 0.0000323 AC XY: 3AN XY: 92840
GnomAD4 exome AF: 0.0000120 AC: 17AN: 1413742Hom.: 0 Cov.: 41 AF XY: 0.0000129 AC XY: 9AN XY: 698784
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152402Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74520
ClinVar
Submissions by phenotype
not provided Uncertain:4
The MYLK c.1786G>A; p.Ala596Thr variant (rs758715543), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 471704). This variant is only observed on three alleles in the Genome Aggregation Database, indicating it is not a common polymorphism. The alanine at codon 596 is weakly conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.462). Due to limited information, the clinical significance of the p.Ala596Thr variant is uncertain at this time. -
In silico analysis supports that this missense variant does not alter protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge -
- -
- -
Aortic aneurysm, familial thoracic 7 Uncertain:2
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 596 of the MYLK protein (p.Ala596Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with aortic dissection and/or dilatation (internal data). ClinVar contains an entry for this variant (Variation ID: 471704). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MYLK protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as VUS-3B. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with familial thoracic aortic aneurysm, 7 (MIM#613780). (I) 0108 - This gene is associated with both recessive and dominant disease. This gene is associated with autosomal dominant familial thoracic aortic aneurysm, 7 (MIM#613780) although homozygous carriers with more early-onset severe disease have also been reported, and autosomal recessive megacystis-microcolon-intestinal hypoperistalsis syndrome (MIM#249210) (PMID: 29544503; OMIM). (I) 0112 - The condition associated with this gene has incomplete penetrance (PMID: 29544503; OMIM). (I) 0115 - Variants in this gene are known to have variable expressivity (PMID: 29544503). (I) 0200 - Variant is predicted to result in a missense amino acid change from alanine to threonine. (I) 0219 - This variant is non-coding in an alternative transcript. This variant is non-coding in the NM_053031.4 and NM_053032.4 transcripts. Although these transcripts are more widely expressed than our chosen transcript, the variant is located in an exon (exon 13) which has increased expression in the aorta, our tissue of interest, compared to other tissues (UCSC, GTEx). (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) <0.001 for a dominant condition (10 heterozygotes, 0 homozygotes). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated Ig-like C2-type 4 domain (UniProt). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0809 - Previous evidence of pathogenicity for this variant is inconclusive. This variant has been classified as a VUS in Clinvar. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Familial thoracic aortic aneurysm and aortic dissection Uncertain:2
The p.A596T variant (also known as c.1786G>A), located in coding exon 10 of the MYLK gene, results from a G to A substitution at nucleotide position 1786. The alanine at codon 596 is replaced by threonine, an amino acid with some similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at